ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Remote Steroid Wean is Safe When Compared to Early Wean in Heart Transplant Recipients

B. C. Salgado, J. Krisl, E. A. Graviss, D. T. Nguyen, A. Bhimaraj, A. Guha

Cardiovascular Disease, Heart Failure and Transplant, Houston Methodist Hospital, Houston, TX

Meeting: 2020 American Transplant Congress

Abstract number: B-260

Keywords: Graft function, Immunosuppression, Rejection

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session B: Heart and VADs: All Topics

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Prednisone Wean After Dual Heart and Kidney Transplantation: Is There a Risk?
  • Potential Downfall of Failed Prednisone Wean after Heart Transplant

*Purpose: The risks and benefits of remote steroid wean in heart transplant recipients is unknown. We compared outcomes in patients undergoing early and remote steroid wean after heart transplantation.

*Methods: We performed a retrospective study comparing early vs. late prednisone wean in patients with heart transplantation. Primary outcomes included mortality, graft dysfunction and burden of rejection. Secondary outcomes included change in hemoglobin A1c, LDL cholesterol, triglycerides, T-score dexa-score, body mass index (BMI) before and after the wean. Patients characteristics and outcomes were stratified by early or remote steroid weaning. Differences between early and remote groups were determined by the Chi-square or Fisher’s exact tests for categorical variables and Kruskal Wallis test for continuous variables. All the analyses were performed on Stata version 16.0 (StataCorp LLC, College Station, TX, USA). A p-value of <0.05 was considered statistically significant.

*Results: A total of 63 patients underwent our steroid wean protocol between 2012 and 2017. Outcomes of patients weaned at 1 year (n= 34; median time from transplant= 1.1 years) were compared with those weaned after 2 years (n=29; median time from transplantation= 4.4 years). No significant difference was found between the number of patients successfully weaned in the early group (88.2%) and remote group (79.3%) (p-value 0.33). There were no differences in graft function (p-value 0.08), prevalence of rejection (p-value 0.46) or survival up to 3 years (p-value 0.09) in patients with early as compared with remote wean (table 1). Improvement in metabolic profile was seen in both groups however these were not statistically significant (table 2).

*Conclusions: There were no differences in graft function, prevalence of rejection or survival up to 3 years in patients with early as compared with remote wean.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Salgado BC, Krisl J, Graviss EA, Nguyen DT, Bhimaraj A, Guha A. Remote Steroid Wean is Safe When Compared to Early Wean in Heart Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/remote-steroid-wean-is-safe-when-compared-to-early-wean-in-heart-transplant-recipients/. Accessed April 15, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.